{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:24:37Z","timestamp":1767155077130,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"University of Istanbul Scientific Research Projects Unit"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.pnpbp.2011.10.010","type":"journal-article","created":{"date-parts":[[2011,10,20]],"date-time":"2011-10-20T14:38:41Z","timestamp":1319121521000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serotonin-2a receptor and catechol-O-methyltransferase polymorphisms in panic disorder"],"prefix":"10.1016","volume":"36","author":[{"given":"Gul","family":"Karacetin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Bayoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujgan","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turkay","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nese","family":"Kocabasoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reha","family":"Bayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Balcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2000","series-title":"Diagnostic and statistical manual of mental disorders, text revision","author":"American Psychiatric Association","key":"10.1016\/j.pnpbp.2011.10.010_bb0005"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.psychres.2009.11.022","article-title":"Association between the catechol-O-methyltransferase Val158Met polymorphism and panic disorder: a replication","volume":"178","author":"Annerbrink","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for panic disorder and agoraphobia: II. The Panic and Agoraphobia Scale","volume":"10","author":"Bandelow","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psychres.2004.02.001","article-title":"Moderating effects of major depression on patterns of comorbidity in patients with panic disorder","volume":"126","author":"Biederman","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/nbdi.1999.0262","article-title":"The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia","volume":"6","author":"Bondy","year":"1999","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0169-328X(92)90005-V","article-title":"The human 5-HT2 receptors encoded by a multiple intron-exon gene","volume":"14","author":"Chen","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1023680302975","article-title":"The role of catechol-O-methyltransferase in the inactivation of catecholestrogen","volume":"23","author":"Creveling","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S146114570400416X","article-title":"Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women","volume":"7","author":"Domschke","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ajmg.b.30494","article-title":"Meta-analysis of COMT Val158met in panic disorder: ethnic heterogeneity and gender specificity","volume":"144","author":"Domschke","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pscychresns.2007.04.016","article-title":"Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder","volume":"163","author":"Domschke","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0055","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/archpsyc.63.12.1396","article-title":"Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation","volume":"63","author":"Drabant","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0060","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0278-5846(00)00130-5","article-title":"Panic, hyperventilation and perpetuation of anxiety","volume":"24","author":"Dratcu","year":"2000","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00041444-200303000-00006","article-title":"Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism","volume":"13","author":"Enoch","year":"2003","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/da.10114","article-title":"Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive\u2013compulsive disorder","volume":"18","author":"Erdal","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0070","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0085","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0278-5846(01)00171-3","article-title":"Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy","volume":"25","author":"Fehr","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0031-9384(02)00909-5","article-title":"Regulation of conditioned responses of basolateral amygdala neurons","volume":"77","author":"Grace","year":"2002","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4088\/JCP.v67n0305","article-title":"The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Grant","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0105","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/da.20615","article-title":"Linkage and association studies of anxiety disorders","volume":"26","author":"Hamilton","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0006-3223(01)01322-1","article-title":"Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22","volume":"51","author":"Hamilton","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0110","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.158.10.1568","article-title":"A review and meta-analysis of the genetic epidemiology of anxiety disorders","volume":"158","author":"Hettema","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biopsych.2008.03.014","article-title":"Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes","volume":"64","author":"Hettema","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-1781(03)00064-7","article-title":"Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene","volume":"118","author":"Inada","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0278-5846(94)90064-7","article-title":"Serotonergic function in panic disorder: endocrine responses to D-fenfluramine","volume":"18","author":"Judd","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0130","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1073\/pnas.94.9.4572","article-title":"Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive\u2013compulsive disorder","volume":"94","author":"Karayiorgou","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0135","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1471-4159.1996.66020589.x","article-title":"The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area","volume":"66","author":"Karreman","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0278-5846(93)90005-D","article-title":"Course and outcome in panic disorder","volume":"17","author":"Keller","year":"1993","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","article-title":"The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-244X-10-99","article-title":"The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive\u2013behavioral treatment in panic disorder","volume":"10","author":"Lonsdorf","year":"2010","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300880","article-title":"Serotonin function in panic disorder: important, but why?","volume":"31","author":"Maron","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00041444-200503000-00004","article-title":"Association study of 90 candidate gene polymorphisms in panic disorder","volume":"15","author":"Maron","year":"2005","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0170","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/mp.2009.145","article-title":"Advances in molecular genetics of panic disorder","volume":"15","author":"Maron","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0185","first-page":"210","article-title":"Serotonin gene polymorphisms in patients with panic disorder","volume":"33","author":"Mart\u00ednez-Barrondo","year":"2005","journal-title":"Actas Esp Psiquiatr"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0190","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/da.20674","article-title":"The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"27","author":"Nepon","year":"2010","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-1781(98)00062-6","article-title":"No association between anxiety disorders and catechol-O-methyltransferase polymorphism","volume":"80","author":"Ohara","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0278-5846(90)90045-I","article-title":"Sleep studies and neurochemical correlates in panic disorder and agoraphobia","volume":"14","author":"Pecknold","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.pnpbp.2007.07.029","article-title":"Panic, suffocation false alarms, separation anxiety and endogenous opioids","volume":"32","author":"Preter","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0278-5846(85)90177-0","article-title":"Panic disorder: response to sodium lactate and treatment with antidepressants","volume":"9","author":"Rifkin","year":"1985","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0215","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2004.04.010","article-title":"Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany","volume":"363","author":"Rothe","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0220","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.npp.1301048","article-title":"Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder","volume":"31","author":"Rothe","year":"2006","journal-title":"Neuropsychopharmacology"},{"year":"2008","series-title":"Stahl's essential psychopharmacology: neuroscientific basis and practical appplications","author":"Stahl","key":"10.1016\/j.pnpbp.2011.10.010_bb0225"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0887-6185(02)00104-4","article-title":"Assessing the severity of panic disorder and agoraphobia. Validity, reliability and objectivity of the Turkish translation of the panic and agoraphobia scale","volume":"16","author":"Tural","year":"2002","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0235","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajmg.b.30412","article-title":"Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder","volume":"144","author":"Unschuld","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/hmg\/2.3.338","article-title":"An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis","volume":"2","author":"Warren","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0260","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.159.10.1785","article-title":"Catechol O-methyltransferase genetic polymorphism in panic disorder","volume":"159","author":"Woo","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0255","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpsychires.2004.01.001","article-title":"The association between panic disorder and the L\/L genotype of catechol-O-methyltransferase","volume":"38","author":"Woo","year":"2004","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.psychres.2009.08.004","article-title":"High prevalence of comorbidity of migraine in outpatients with panic disorder and effectiveness of psychopharmacotherapy for both disorders: a retrospective open label study","volume":"185","author":"Yamada","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0270","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/da.20239","article-title":"Correlations of quality of life with adverse effects of medication, social support, course of illness, psychopathology, and demographic characteristics in patients with panic disorder","volume":"24","author":"Yen","year":"2007","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0165-1781(00)00119-0","article-title":"Increased QT variability in patients with panic disorder and depression","volume":"93","author":"Yeragani","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0280","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.janxdis.2008.03.006","article-title":"The association between serotonin related gene polymorphisms and panic disorder","volume":"22","author":"Yoon","year":"2008","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.pnpbp.2011.10.010_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/YPG.0b013e3280d6472e","article-title":"Is 472G\/A catechol-O-methyl-transferase gene polymorphism related to panic disorder?","volume":"17","author":"Zintzaras","year":"2007","journal-title":"Psychiatr Genet"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:42:18Z","timestamp":1759520538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0278584611003071"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.10.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin-2a receptor and catechol-O-methyltransferase polymorphisms in panic disorder","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}